Permeasis Therapeutics
PrivateLast Round
Seed
Oct 10, 2024
Company Overview
Permeasis Therapeutics is a biotechnology company developing intracellular biologics enabled by its proprietary Membrane Translocation Domain (MTD) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Permeasis Therapeutics Comparables
Compare Permeasis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CyGenica | 85% | |
| Feldan Therapeutics | 84% | |
| Xelcis Bio, Inc. | 82% | |
Permeasis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 10, 2024 |
Permeasis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cure Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2024
Seed round led by Cure Ventures.
Permeasis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Permeasis Therapeutics's valuation, stock price, and market status.